Cargando…
Is the Fixed-Dose Intravenous Trastuzumab Policy Warranted in Limited-Resource Settings?
Autores principales: | Kassem, Loay, Shohdy, Kyrillus S., Abdel-Azeez, Ahmad M., Attia, Hanaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426478/ https://www.ncbi.nlm.nih.gov/pubmed/30676841 http://dx.doi.org/10.1200/JGO.18.00155 |
Ejemplares similares
-
Prognostic Impact of Cytotoxic CD4 T Cells in Tumor Immune Microenvironment of Patients with Breast Cancer
por: Shohdy, Kyrillus S., et al.
Publicado: (2021) -
Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin
por: Abdel Azim, Hamdy, et al.
Publicado: (2018) -
Availability of Informal Caregivers for Palliative Care Patients with Cancer: Is there a Difference between Higher- and Lower-Income Settings
por: Abdel-Malek, Raafat, et al.
Publicado: (2019) -
Pathological responses and survival outcomes in patients with locally advanced breast cancer after neoadjuvant chemotherapy: a single-institute experience
por: Shohdy, Kyrillus S., et al.
Publicado: (2021) -
Intravenous fluids: issues warranting concern
por: Mertzlufft, Friedrich, et al.
Publicado: (2022)